Our facility is reviewing the use of allergy bracelets.  Is anyone aware of best practice recommendations round the use of allergy bracelets?  Any input would be greatly appreciated.

Thanks in advance!

Amanda

Looking for policies/examples of how excipient and preservative allergies are handled? For those ingredients that electronic systems do not scan for, or alert against, what procedures are in place?

We are currently working on a policy for administration of intranasal midazolam and fentanyl for patients in ED, out patient suregery, and pediatrics without an IV site.  Doses anyone have any policies or experience with this route of administration they would like to share?

Thanks,

Melinda

Hello Everyone,

Does anyone have any protocols in place for infusing 3% saline? If so, would you be willing to share?

Thanks in advance,

Stephanie

Has anyone out there successfully implemented all 12 Targeted Best Practices? I would be interested in talking with you! Thanks!

Hello,

We are interested in knowing how other institutions enter their patient's home medications.  At our institution, we currently enter a dummy "POM" medication into the patient's profile.  However, this dummy record does not perform a drug interaction check for new or existing orders. We currently have Meditech version 5.6.6.  Our current process relies on a manual check which allows for POMs drug interactions to be missed.  Any feedback or suggestions on the following questions are appreaciated:

1- How does your institution enter patient's home medication?

Currently, MSOS has the ability to send members notices of new posts (and comments to existing posts) on our Forum, either immediately (as they are posted), or once a day.  We want your opinion on which frequency you wish to receive emails regarding posts to the forum - daily or immediately. Please don't respond to this post, but go to the poll in left column of the website main or forum page(s). We will select the highest voted frequency for our postings.

We did a brief article in today's ISMP newsletter related to the recent tragic error in Oregon where a neuromuscular blocker was prepared in a bag labeled fosphenytoin.

http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=97

The Strategies Worth Sharing session is scheduled for Wednesday, June 10, 2015 from 8 -10 am at the 2015 Medication Safety Collaborative. Notice that this session used to be called “Best Practices” but has been renamed to avoid confusion with the ASHP award program called Best Practices.